Masayuki Imamura

Summary

Affiliation: Kansai Denryoku Hospital
Country: Japan

Publications

  1. pmc Recent standardization of treatment strategy for pancreatic neuroendocrine tumors
    Masayuki Imamura
    Department of Surgey, Kansai Denryoku Hospital, 2 1 7, Fukushima, Fukushima ku, Osaka 553 0003, Japan
    World J Gastroenterol 16:4519-25. 2010
  2. pmc Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients
    Masayuki Imamura
    Department of Surgery, Kansa Electric Power Company Hospital, Osaka, Japan
    World J Gastroenterol 17:1343-53. 2011
  3. ncbi request reprint Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer
    Ryuichiro Doi
    Department of Surgery, Kyoto University, 54 Shogoinkawaracho, Sakyo, Kyoto, Japan
    World J Surg 31:147-54. 2007
  4. ncbi request reprint Predictive factors affecting early recurrence after hepatectomy for hepatocellular carcinoma in 5-year survivors
    Toshimi Kaido
    Department of Surgery, Otsu Municipal Hospital, Shiga, Japan
    Hepatogastroenterology 52:1484-7. 2005
  5. ncbi request reprint Tissue factor is a useful prognostic factor of recurrence in hepatocellular carcinoma in 5-year survivors
    Toshimi Kaido
    Department of Surgery, Otsu Municipal Hospital, Shiga, Japan
    Hepatogastroenterology 52:1383-7. 2005
  6. ncbi request reprint Changing treatment strategy for gastrinoma in patients with Zollinger-Ellison syndrome
    Masayuki Imamura
    Department of Surgery, Osaka Saiseikai Noe Hospital, Imafuku Higashi 2 2 33, Joto ku, Osaka, 536 0002, Japan
    World J Surg 30:1-11. 2006
  7. doi request reprint Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: final results of a randomized multi-institutional trial
    Ryuichiro Doi
    Department of Surgery, Kyoto University, 54 Shogoinkawaracho, Sakyo ku, Kyoto, 606 8507, Japan
    Surg Today 38:1021-8. 2008
  8. doi request reprint Surgery for a gastroenteropancreatic neuroendocrine tumor (GEPNET) in multiple endocrine neoplasia type 1
    Kazuhiro Hanazaki
    Department of Surgery, Kochi Medical School, Kochi University, Kohasu, Okocho, Nankoku, Kochi, 783 8505, Japan
    Surg Today 43:229-36. 2013
  9. ncbi request reprint [Treatment for pancreatic endocrine tumors with or without multiple endocrine neoplasia type 1]
    Masayuki Imamura
    Kyoto University, Director Osaka Saiseikai Noe Hospital, Osaka, Japan
    Nihon Geka Gakkai Zasshi 106:472-8. 2005
  10. ncbi request reprint [Recent advances in treatment of pancreatic neuroendocrine tumors]
    Masayuki Imamura
    Kyoto University, Osaka, Japan
    Nihon Geka Gakkai Zasshi 109:143-6. 2008

Detail Information

Publications15

  1. pmc Recent standardization of treatment strategy for pancreatic neuroendocrine tumors
    Masayuki Imamura
    Department of Surgey, Kansai Denryoku Hospital, 2 1 7, Fukushima, Fukushima ku, Osaka 553 0003, Japan
    World J Gastroenterol 16:4519-25. 2010
    ..The usefulness of octreotide treatment and other molecular targeting agents are currently being assessed...
  2. pmc Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients
    Masayuki Imamura
    Department of Surgery, Kansa Electric Power Company Hospital, Osaka, Japan
    World J Gastroenterol 17:1343-53. 2011
    ..To search for the optimal surgery for gastrinoma and duodenopancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1...
  3. ncbi request reprint Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer
    Ryuichiro Doi
    Department of Surgery, Kyoto University, 54 Shogoinkawaracho, Sakyo, Kyoto, Japan
    World J Surg 31:147-54. 2007
    ..The patients with a short survival time may have identifiable clinicopathologic factors that lead to rapid relapse...
  4. ncbi request reprint Predictive factors affecting early recurrence after hepatectomy for hepatocellular carcinoma in 5-year survivors
    Toshimi Kaido
    Department of Surgery, Otsu Municipal Hospital, Shiga, Japan
    Hepatogastroenterology 52:1484-7. 2005
    ..This study was undertaken to establish a therapeutic strategy for long-term recurrence-free survival in hepatocellular carcinoma (HCC) patients treated by hepatectomy by determining the factors that predict intrahepatic recurrence...
  5. ncbi request reprint Tissue factor is a useful prognostic factor of recurrence in hepatocellular carcinoma in 5-year survivors
    Toshimi Kaido
    Department of Surgery, Otsu Municipal Hospital, Shiga, Japan
    Hepatogastroenterology 52:1383-7. 2005
    ..TF has recently been reported to play an important role in tumor metastasis. The aim of this study was to evaluate the role and the prognostic value of TF in hepatocellular carcinoma (HCC) in long-term survivors...
  6. ncbi request reprint Changing treatment strategy for gastrinoma in patients with Zollinger-Ellison syndrome
    Masayuki Imamura
    Department of Surgery, Osaka Saiseikai Noe Hospital, Imafuku Higashi 2 2 33, Joto ku, Osaka, 536 0002, Japan
    World J Surg 30:1-11. 2006
    ....
  7. doi request reprint Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: final results of a randomized multi-institutional trial
    Ryuichiro Doi
    Department of Surgery, Kyoto University, 54 Shogoinkawaracho, Sakyo ku, Kyoto, 606 8507, Japan
    Surg Today 38:1021-8. 2008
    ..The preliminary results of our multi-institutional randomized controlled trial revealed better survival after surgery than after radiochemotherapy. We report the final results of this study after 5 years of follow-up...
  8. doi request reprint Surgery for a gastroenteropancreatic neuroendocrine tumor (GEPNET) in multiple endocrine neoplasia type 1
    Kazuhiro Hanazaki
    Department of Surgery, Kochi Medical School, Kochi University, Kohasu, Okocho, Nankoku, Kochi, 783 8505, Japan
    Surg Today 43:229-36. 2013
    ..This article reviews the clinical characteristics in these patients with a particular focus on surgery, diagnosis, surgical indications, surgical method, and surgical outcome...
  9. ncbi request reprint [Treatment for pancreatic endocrine tumors with or without multiple endocrine neoplasia type 1]
    Masayuki Imamura
    Kyoto University, Director Osaka Saiseikai Noe Hospital, Osaka, Japan
    Nihon Geka Gakkai Zasshi 106:472-8. 2005
    ..Subtotal distal pancreatectomy or pancreas-preserving total duodenectomy is indicated for multiple pancreatic endocrine tumors and multiple duodenal gastrinomas, respectively, for patients with multiple endocrine neoplasia type 1...
  10. ncbi request reprint [Recent advances in treatment of pancreatic neuroendocrine tumors]
    Masayuki Imamura
    Kyoto University, Osaka, Japan
    Nihon Geka Gakkai Zasshi 109:143-6. 2008
    ..In liver metastasis of PNET, mass reduction surgery with hepatectomy improves the prognosis of patients, and octreotide LAR has been shown to be useful for reducing complications and inhibiting the growth of tumors...
  11. ncbi request reprint [Delay in the introduction of treatment modalities for neuroendocrine tumors in Japan]
    Masayuki Imamura
    Kansai Electric Power Hospital, Endocrine Tumor Center
    Gan To Kagaku Ryoho 40:847-50. 2013
    ..In Japan, a few diagnostic and treatment modalities including somatostatin receptor scintigraphy(SRS)have not been approved by the government. Therefore, we intend to improve this situation as soon as possible. ..
  12. ncbi request reprint STAT1 activation-induced apoptosis of esophageal squamous cell carcinoma cells in vivo
    Junichi Kaganoi
    Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606 8507, Japan
    Ann Surg Oncol 14:1405-15. 2007
    ....
  13. ncbi request reprint Interleukin-6 augments hepatocyte growth factor-induced liver regeneration; involvement of STAT3 activation
    Toshimi Kaido
    Department of Surgery, Otsu Municipal Hospital, Shiga, Japan
    Hepatogastroenterology 51:1667-70. 2004
    ..We therefore investigated the effect of IL-6 on liver regeneration and examined STAT3 activation following IL-6 and/or HGF treatment in rats...
  14. ncbi request reprint Repeated resection for extrahepatic recurrences after hepatectomy for ruptured hepatocellular carcinoma
    Toshimi Kaido
    Department of Surgery, Otsu Municipal Hospital, 2 9 9 Motomiya, Otsu, Shiga 520 0804, Japan
    J Hepatobiliary Pancreat Surg 11:149-52. 2004
    ..This is an extremely rare case of a patient who successfully underwent five repeated resections for extrahepatic recurrences after hepatectomy for ruptured HCC...
  15. ncbi request reprint RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis
    Toshihiko Masui
    Department of Surgery, Kyoto University Graduate School of Medicine, Sakyo, Japan
    Clin Cancer Res 9:1779-84. 2003
    ..We also analyzed the correlation between RECK expression and MMP activation...